Protein quality control mechanisms of novel soluble substrates
Protein quality control mechanisms of novel soluble substrates
批准号:
8836557
负责人:
Michael John Palladino
金额:
$28.69万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2017-04-30
关键词:
AffectC-terminalDataDegradation PathwayDetectionDiseaseDisease modelDrosophila genusDrosophila inturned proteinEngineeringExhibitsFunctional disorderGenesGenomicsHealthHumanHuman EngineeringHydrophobicityIndividualIsomeraseLearningLongevityMissense MutationMitochondrial MatrixMolecularMutationPathogenesisPathway interactionsPropertyProteinsQuality ControlRNA InterferenceSolubilityStructureSurfaceSystemTestingTransgenic OrganismsUbiquitinbasedimerdisease-causing mutationhuman SOD2 proteinhuman diseasein vivomulticatalytic endopeptidase complexmutantnovelprematurepreventprotein structureresearch studysenescence
中文摘要
描述(由申请人提供):正常细胞健康需要蛋白质质量控制机制,以预防疾病和避免过早衰老。 独特的突变蛋白是这些途径的底物,被蛋白质质量控制途径组分识别,并且通常被蛋白酶体降解。 具有微小错义突变的蛋白质可以保留功能,但这些途径的降解可以成为发病机制的基础。 蛋白质质量控制底物识别的分子和物理基础知之甚少,特别是可溶性胞质蛋白。 本申请提出使用强大的多学科方法来定义蛋白质质量控制途径中的新型蛋白质,并阐明底物识别的物理和结构基础。
英文摘要
DESCRIPTION (provided by applicant): Protein quality control mechanisms are required for normal cellular health to prevent disease and avoid premature senescence. Unique mutant proteins are substrates of these pathways, are recognized by protein quality control pathway components and typically degraded by the proteasome. Proteins with subtle missense mutations can retain function yet degradation by these pathways can underlie pathogenesis. The molecular and physical basis of protein quality control substrate recognition are poorly understood, especially for soluble cytosolic proteins. This application proposes to use a powerful multi disciplinary approach to define novel proteins in the protein quality control pathway and elucidate the physical and structural basis of substrate recognition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing the first TPI Df therapeutics
-
批准号:10393677
-
项目类别:
-
资助金额:$54.32万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
Developing the first TPI Df therapeutics
-
批准号:10613470
-
项目类别:
-
资助金额:$53.85万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
Developing the first TPI Df therapeutics
-
批准号:10229007
-
项目类别:
-
资助金额:$54.35万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
Developing a murine TPI Df model
-
批准号:10294798
-
项目类别:
-
资助金额:$15.78万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
High-content screening for TPI Deficiency therapeutics
-
批准号:10662471
-
项目类别:
-
资助金额:$54.33万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
High-content screening for TPI Deficiency therapeutics
-
批准号:10312211
-
项目类别:
-
资助金额:$57.85万
-
财政年份:2021
-
负责人:Michael John Palladino
-
依托单位:
Genetic modulation of mitochondrial function
-
批准号:9542442
-
项目类别:
-
资助金额:$23.44万
-
财政年份:2018
-
负责人:Michael John Palladino
-
依托单位:
Pre-clinical studies of novel mitochondrial gene therapies
-
批准号:9036405
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2015
-
负责人:Michael John Palladino
-
依托单位:
Determining the cellular and molecular basis of mitochondrial encephalomyopathy seizures
-
批准号:9150332
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2015
-
负责人:Michael John Palladino
-
依托单位:
Pre-clinical studies of novel mitochondrial gene therapies
-
批准号:9411127
-
项目类别:
-
资助金额:$28.68万
-
财政年份:2015
-
负责人:Michael John Palladino
-
依托单位:
Pre-clinical studies of novel mitochondrial gene therapies
-
批准号:9212818
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2015
-
负责人:Michael John Palladino
-
依托单位:
Mitochondrial RNA transport as a novel therapy
-
批准号:8412983
-
项目类别:
-
资助金额:$18.27万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Protein quality control mechanisms of novel soluble substrates
-
批准号:8402430
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Protein quality control mechanisms of novel soluble substrates
-
批准号:8646931
-
项目类别:
-
资助金额:$28.52万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Protein quality control mechanisms of novel soluble substrates
-
批准号:8518415
-
项目类别:
-
资助金额:$27.63万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Mitochondrial RNA transport as a novel therapy
-
批准号:8271020
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2012
-
负责人:Michael John Palladino
-
依托单位:
Mitochondrial Dysfunction and Progressive Encephalomyopathies
-
批准号:7927102
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2009
-
负责人:Michael John Palladino
-
依托单位:
Mitochondrial Dysfunction and Progressive Encephalomyopathies
-
批准号:7686654
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2009
-
负责人:Michael John Palladino
-
依托单位:
TEM TOMOGRAPHY OF A DROSOPHILA ATP6 MUTATION
-
批准号:7721714
-
项目类别:
-
资助金额:$1.11万
-
财政年份:2008
-
负责人:Michael John Palladino
-
依托单位:
TEM TOMOGRAPHY OF A DROSOPHILA ATP6 MUTATION
-
批准号:7598374
-
项目类别:
-
资助金额:$0.46万
-
财政年份:2007
-
负责人:Michael John Palladino
-
依托单位:
国内基金
海外基金
MUC16 C-terminal/AKT/HK2信号轴在Lewis抗原阴性胰腺癌侵袭转移中的作用及机制研究
-
批准号:82072693
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:刘辰
-
依托单位:
靶向转导Gαi2 C-terminal peptide基因去迷走神经治疗心房颤动的实验研究
-
批准号:81260037
-
项目类别:地区科学基金项目
-
资助金额:50.0万元
-
批准年份:2012
-
负责人:汤宝鹏
-
依托单位: